Sign up to save your podcasts
Or
Share E123: Upadacitinib for Giant Cell Arteritis: SELECT-GCA
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E123: Upadacitinib for Giant Cell Arteritis: SELECT-GCA
Podcast this week about the recently published SELECT-GCA study, which evaluated the use of the janus kinase inhibitor upadacitinib (Rinvoq) for patients with new and relapsing GCA. Successful trial and an interesting topic. Paper itself here: https://www.nejm.org/doi/full/10.1056/NEJMoa2413449
View all episodes
By Michael Putman
4.9
114114 ratings
Podcast this week about the recently published SELECT-GCA study, which evaluated the use of the janus kinase inhibitor upadacitinib (Rinvoq) for patients with new and relapsing GCA. Successful trial and an interesting topic. Paper itself here: https://www.nejm.org/doi/full/10.1056/NEJMoa2413449
More shows like The Evidence Based Rheumatology Podcast
View all
JAMA Clinical Reviews
498 Listeners
Mayo Clinic Talks
301 Listeners
Rheumnow Podcast
124 Listeners
The Curbsiders Internal Medicine Podcast
3,354 Listeners
Core IM | Internal Medicine Podcast
1,142 Listeners
Healio Rheuminations
120 Listeners
Annals On Call Podcast
199 Listeners
The Clinical Problem Solvers
515 Listeners
ACR on Air
70 Listeners
Around the Rheum with Drs. Daniel Ennis & Janet Pope
4 Listeners
The Curious Clinicians
369 Listeners
Rheumatology For The Royal College
182 Listeners
Febrile
185 Listeners
ACR Journals On Air
20 Listeners
Talking Rheumatology Spotlight
6 Listeners